Clinical Trial Update: Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of bevacizumab plus vinorelbine for stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED